Systemic overexpression of IL-10 induces CD4+CD25+ cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion

Journal of Immunology

Volumn 171, Issue 5, 2003, Pages 2270-2278

  Goudy, Kevin S ^a   Burkhardt, Brant R ^a   Wasserfall, Clive ^a   Song, Sihong ^b   Campbell Thompson, Martha L ^a   Brusko, Todd ^a   Powers, Matthew A ^a   Clare Salzler, Michael J ^a   Sobel, Eric S ^b   Ellis, Tamir M ^a   Flotte, Terence R ^a,b   Atkinson, Mark A ^a,b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD4 ANTIGEN; INSULIN ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OVALBUMIN; PARVOVIRUS VECTOR; RNA; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL POPULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FEMALE; GENE OVEREXPRESSION; GENE THERAPY; HISTOPATHOLOGY; HUMORAL IMMUNITY; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE;

EID: 0042931258     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.5.2270     Document Type: Article

References (31)

1. Atkinson, M., and G. Eisenbarth. 2001. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358:221.
2. Wong, F. S., and C. A. J. Janeway. 1999. The role of CD4 vs. CD8 T cells in IDDM. J. Autoimmun. 13:290.
3. Pearson, C. I., and H. O. McDevitt. 1999. Redirecting Th1 and Th2 responses in autoimmune disease. Curr. Top. Microbiol. Immunol. 238:79.
4. Suarez-Pinzon, W. L., and A. Rabinovitch. 2001. Approaches to type 1 diabetes prevention by intervention in cytokine immunoregulatory circuits, Int. J. Exp. Diabetes Res. 2:3.
5. Atkinson, M. A., and E. H. Leiter. 1999. The NOD mouse model of type 1 diabetes: as good as it gets? Nat. Med. 5:601.
6. Moore, K. W., M. de Waal, R. L. Coffman, and A. O'Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19:683.
7. Ding, Y., D. Chen, A. Tarcsafalvi, R. Su, L. Qin, and J. S. Bromberg. 2003. Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses. J. Immunol. 170:1383.
8. Muller, G., A. Muller, T. Tuting, K. Steinbrink, J. Saloga, C. Szalma, J. Knop, and A. H. Enk. 2002. Interleukin-10-treated dendritic cells modulate immune responses of naive and sensitized T cells in vivo. J. Invest. Dermatol. 119:836.
9. - regulatory T cells in vivo in humans. Blood 100:174.
10. Dhodapkar, M. V., R. M. Steinman, J. Krasovsky, C. Munz, and N. Bhardway. 2001. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193:233.
11. - T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. 197:111.
12. - immunoregulatory T cells that control autoimmune diabetes. Immunity 12:431.
13. - T cell levels in NOD mice. Proc. Natl. Acad. Sci. USA 99:12287.
14. Groux, H. 2001. An overview of regulatory T cells. Microbes Infect. 3:883.
15. Balasa, B., and N. Sarvetnick. 1996. The paradoxical effects of interleukin 10 in the immunoregulation of autoimmune diabetes. J. Autoimmun. 9:283.
16. Balasa, B., K. Van Gunst, N. Jung, J. D. Katz, and N. Sarvetnick. 2000. IL-10 deficiency does not inhibit insulitis and accelerates cyclophosphamide-induced diabetes in the nonobese diabetic mouse. Cell. Immunol. 202:97.
17. Pennline, K. J., E. Roque-Gaffney, and M. Monahan. 1994. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin. Immunol. Immunopathol. 71:169.
18. Nitta, Y., F. Tashiro, M. Tokui, A. Shimada, I. Takei, K. Tabayashi, and J. Miyazaki. 1998. Systemic delivery of interleukin 10 by intramuscular injection of expression plasmid DNA prevents autoimmune diabetes in nonobese diabetic mice. Hum. Gene Ther. 9:1701.
19. Moritani, M., K. Yoshimoto, F. Tashiro, C. Hashimoto, J. Miyazaki, S. Ii, E. Kudo, H. Iwahana, Y. Hayashi, and T. Sano. 1994. Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice. Int. Immunol. 6:1927.
20. Wogensen, L., M. S. Lee, and N. Sarvetnick. 1994. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of β cells in nonobese diabetic mice. J. Exp. Med. 179:1379.
21. Smith, D. K., G. S. Korbutt, W. L. Suarez-Pinzon, D. Kao, R. V. Rajotte, and J. F. Elliott. 1997. Interleukin-4 or interleukin-10 expressed from adenovirus-transduced syngeneic islet grafts fails to prevent beta cell destruction in diabetic NOD mice. Transplantation 64:1040.
22. Szelachowska, M., A. Kretowski, and I. Kinalska. 1998. Decreased in vitro IL-4 and IL-10 production by peripheral blood in first degree relatives at high risk of diabetes type-I. Horm. Metab. Res. 30:526.
23. Alleva, D. G., R. P. Pavlovich, C. Grant, S. B. Kaser, and D. I. Beller. 2000. Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-alpha and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice. Diabetes 49:1106.
24. Song, S., M. Morgan, T. Ellis, A. Poirier, K. Chesnut, J. Wang, M. Brantly, N. Muzyczka, B. J. Byrne, M. Atkinson, et al. 1998. Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors. Proc. Natl. Acad. Sci. USA 95:14384.
25. Rabinowitz, J. E., and J. Samulski. 1998. Adeno-associated virus expression systems for gene transfer. Curr. Opin. Biotechnol. 9:470.
26. Goudy, K., S. Song, C. Wasserfall, Y. C. Zhang, M. Kapturczak, A. Muir, M. Powers, M. Scott-Jorgensen, M. Campbell-Thompson, J. M. Crawford, et al. 2001. Adeno-associated virus vector mediated interleukin-10 gene delivery prevents type 1 diabetes in NOD mice. Proc. Natl. Acad. Sci. USA 98:13913.
27. Yang, Z., M. Chen, R. Wu, L. B. Fialkow, J. S. Bromberg, M. McDuffie, A. Naji, and J. L. Nadler. 2002. Suppression of autoimmune diabetes by viral IL-10 gene transfer. J. Immunol. 168:6479.
28. - splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J. Immunol. 169:2461.
29. Singh, B., S. Read, C. Asseman, V. Malmstrom, C. Mottet, L. A. Stephens, R. Stepankova, H. Tlaskalova, and F. Powrie. 2001. Control of intestinal inflammation by regulatory T cells. Immunol. Rev. 182:190.
30. Levings, M. K., R. Sangregorio, F. Galbiati, S. Squadrone, M. R. de Waal, and M. G. Roncarolo. 2001. IFN-α and IL-10 induce the differentiation of human type 1 T regulatory cells. J. Immunol. 166:5530.
31. + anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. Blood 93:1634.